Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial (Q34647669)

3 August 2017

Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial (English)

1 reference

3 August 2017

0 references

0 references

0 references

Ali Ahmed

12

0 references

Marco Metra

Marco Metra

7

0 references

Mihai Gheorghiade

1

Mihai Gheorghiade

1 reference

3 August 2017

3

Gerasimos Filippatos

1 reference

3 August 2017

4

Stefan D Anker

1 reference

PubMed ID

23355060

3 August 2017

Dirk J van Veldhuisen

5

Dirk J van Veldhuisen

1 reference

3 August 2017

8

Inmaculada B Aban

0 references

John McMurray

11

John J V McMurray

1 reference

3 August 2017

2

Kanan Patel

1 reference

3 August 2017

10

Kirkwood F Adams

1 reference

3 August 2017

9

Stephen J Greene

1 reference

3 August 2017

John G F Cleland

6

1 reference

3 August 2017

25 January 2013

1 reference

European Journal of Heart Failure

3 August 2017

1 reference

3 August 2017

15

1 reference

3 August 2017

551-559

1 reference

3 August 2017

5

1 reference

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Rehospitalizations among patients in the Medicare fee-for-service program

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

The underuse of digoxin in heart failure, and approaches to appropriate use.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3707428

Determination of vital status at the end of the DIG trial.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT010

Association between performance measures and clinical outcomes for patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT010

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT010

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT010

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT010

Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT010

Reconsidering the role for digoxin in the management of acute heart failure syndromes

21 January 2018

1 reference

12 December 2020

Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure

1 reference

12 December 2020

Digoxin reduces cardiac sympathetic activity in severe congestive heart failure

1 reference

12 December 2020

Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

12 December 2020

Digitalis and baroreceptor reflexes in man

1 reference

12 December 2020

Low-dose digoxin in patients with heart failure. Less toxic and at least as effective?

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURJHF/HFT010

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

23355060